These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 24659638)
1. Pathogenesis and regulation of cellular proliferation in acute lymphoblastic leukemia - the role of Ikaros. Wang H; Ouyang H; Lai L; Petrovic-Dovat L; Stankov K; Bogdanovic G; Dovat S J BUON; 2014; 19(1):22-8. PubMed ID: 24659638 [TBL] [Abstract][Full Text] [Related]
2. Transcriptional Regulation of Genes by Ikaros Tumor Suppressor in Acute Lymphoblastic Leukemia. Dhanyamraju PK; Iyer S; Smink G; Bamme Y; Bhadauria P; Payne JL; Dovat E; Klink M; Ding Y Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32085659 [TBL] [Abstract][Full Text] [Related]
3. Ikaros and tumor suppression in acute lymphoblastic leukemia. Payne KJ; Dovat S Crit Rev Oncog; 2011; 16(1-2):3-12. PubMed ID: 22150303 [TBL] [Abstract][Full Text] [Related]
4. Genetic alterations targeting lymphoid development in acute lymphoblastic leukemia. Collins-Underwood JR; Mullighan CG Curr Top Dev Biol; 2011; 94():171-96. PubMed ID: 21295687 [TBL] [Abstract][Full Text] [Related]
5. Regulation of cellular proliferation in acute lymphoblastic leukemia by Casein Kinase II (CK2) and Ikaros. Gowda C; Song C; Kapadia M; Payne JL; Hu T; Ding Y; Dovat S Adv Biol Regul; 2017 Jan; 63():71-80. PubMed ID: 27666503 [TBL] [Abstract][Full Text] [Related]
6. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients. Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia. Ge Z; Guo X; Li J; Hartman M; Kawasawa YI; Dovat S; Song C Oncotarget; 2015 Dec; 6(39):42300-11. PubMed ID: 26517351 [TBL] [Abstract][Full Text] [Related]
8. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Mullighan CG; Miller CB; Radtke I; Phillips LA; Dalton J; Ma J; White D; Hughes TP; Le Beau MM; Pui CH; Relling MV; Shurtleff SA; Downing JR Nature; 2008 May; 453(7191):110-4. PubMed ID: 18408710 [TBL] [Abstract][Full Text] [Related]
9. [Effect of Ikaros in B Cell Acute Lymphoblastic Leukemia]. Zhang HY; Bai H Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):1194-8. PubMed ID: 26314472 [TBL] [Abstract][Full Text] [Related]
10. Analysis of Ikaros family splicing variants in human hematopoietic lineages. Matulić M; Paradzik M; Puskarić BJ; Stipić J; Antica M Coll Antropol; 2010 Mar; 34(1):59-62. PubMed ID: 20432734 [TBL] [Abstract][Full Text] [Related]
11. IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater? Conserva MR; Redavid I; Anelli L; Zagaria A; Tarantini F; Cumbo C; Tota G; Parciante E; Coccaro N; Minervini CF; Minervini A; Specchia G; Musto P; Albano F Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834692 [TBL] [Abstract][Full Text] [Related]
12. Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia. Volejnikova J; Mejstrikova E; Dörge P; Meissner B; Zimmermannova O; Svojgr K; Stanulla M; Cario G; Schrappe M; Stary J; Hrusak O; Trka J; Fronkova E Pediatr Blood Cancer; 2013 Mar; 60(3):420-7. PubMed ID: 22997141 [TBL] [Abstract][Full Text] [Related]
13. Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance. Vitanza NA; Zaky W; Blum R; Meyer JA; Wang J; Bhatla T; Morrison DJ; Raetz EA; Carroll WL Pediatr Blood Cancer; 2014 Oct; 61(10):1779-85. PubMed ID: 24976218 [TBL] [Abstract][Full Text] [Related]
14. Ikaros regulation of the BCL6/BACH2 axis and its clinical relevance in acute lymphoblastic leukemia. Ge Z; Zhou X; Gu Y; Han Q; Li J; Chen B; Ge Q; Dovat E; Payne JL; Sun T; Song C; Dovat S Oncotarget; 2017 Jan; 8(5):8022-8034. PubMed ID: 28030830 [TBL] [Abstract][Full Text] [Related]
15. Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia. Song C; Gowda C; Pan X; Ding Y; Tong Y; Tan BH; Wang H; Muthusami S; Ge Z; Sachdev M; Amin SG; Desai D; Gowda K; Gowda R; Robertson GP; Schjerven H; Muschen M; Payne KJ; Dovat S Blood; 2015 Oct; 126(15):1813-22. PubMed ID: 26219304 [TBL] [Abstract][Full Text] [Related]
16. How new advances in genetic analysis are influencing the understanding and treatment of childhood acute leukemia. Roberts KG; Mullighan CG Curr Opin Pediatr; 2011 Feb; 23(1):34-40. PubMed ID: 21169835 [TBL] [Abstract][Full Text] [Related]
17. High CRLF2 expression associates with IKZF1 dysfunction in adult acute lymphoblastic leukemia without CRLF2 rearrangement. Ge Z; Gu Y; Zhao G; Li J; Chen B; Han Q; Guo X; Liu J; Li H; Yu MD; Olson J; Steffens S; Payne KJ; Song C; Dovat S Oncotarget; 2016 Aug; 7(31):49722-49732. PubMed ID: 27391346 [TBL] [Abstract][Full Text] [Related]
18. Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia. Wang H; Song C; Ding Y; Pan X; Ge Z; Tan BH; Gowda C; Sachdev M; Muthusami S; Ouyang H; Lai L; Francis OL; Morris CL; Abdel-Azim H; Dorsam G; Xiang M; Payne KJ; Dovat S J Biol Chem; 2016 Feb; 291(8):4004-18. PubMed ID: 26655717 [TBL] [Abstract][Full Text] [Related]
19. Relative expression of different Ikaros isoforms in childhood acute leukemia. Meleshko AN; Movchan LV; Belevtsev MV; Savitskaja TV Blood Cells Mol Dis; 2008; 41(3):278-83. PubMed ID: 18675565 [TBL] [Abstract][Full Text] [Related]
20. Protein signaling and regulation of gene transcription in leukemia: role of the Casein Kinase II-Ikaros axis. Gowda CS; Song C; Ding Y; Kapadia M; Dovat S J Investig Med; 2016 Mar; 64(3):735-9. PubMed ID: 26912004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]